^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Final concentration after mixing.

^d Tested in dextrose 5%, Ringer’s injection, lactated, sodium chloride 0.45%, and sodium chloride 0.9%.

^e Tested in dextrose 5% with albumin human 2 mg/mL.

^f Lyophilized formulation tested.

^g Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

^h Varying volumes to simulate varying administration rates.

ⁱ Final concentrations were 1.5 mg/mL of fluconazole and 5 and 20 mcg/mL of tacrolimus.

^j Tested in Ringer’s injection, lactated.

^k Tested in sterile water for injection.

^l Test performed using the formulation WITHOUT edetate disodium.

^m Ampicillin component. Ampicillin in a 2:1 fixed-ratio concentration with sulbactam.

ⁿ Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.

^o Quinupristin and dalfopristin components combined.

^p Trimethoprim component. Trimethoprim in a 1:5 fixed-ratio concentration with sulfamethoxazole.

^q Not specified whether concentration refers to single component or combined components.

^r Test performed using the Cubicin formulation.

^s Tested in both dextrose 5% and sodium chloride 0.9%.

^t Run at 25 mL/hr with dextrose 5% run at 83 mL/hr.

^u Run at 100 mL/hr.

^v Test performed using the formulation WITH edetate disodium.

^w Tested as the premixed infusion solution.

^x Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.

^y Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.